Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Prothrombin activation in eastern tiger snake bite.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 0175411 Publication Model: Print Cited Medium: Print ISSN: 0031-3025 (Print) Linking ISSN: 00313025 NLM ISO Abbreviation: Pathology Subsets: MEDLINE
- Publication Information:
Publication: Jan. 2011- : London : Lippincott Williams & Wilkins
Original Publication: [Surry Hills, NSW, etc., Modern Medicine, etc.]
- Subject Terms:
- Abstract:
Aims: To perform ex vivo studies in eastern tiger snake envenomation which define the haemostatic events associated with prothrombin activation.
Method: Serial studies were performed on plasma from six individuals with evidence of eastern tiger snake envenomation. These analyses were particularly directed to fibrinogen levels, F1 + 2, TAT and evidence of fibrinolysis.
Results: There was a substantial rise in F1 + 2 and thrombin-antithrombin (TAT) complexes in all cases, even with minimal evenomation. In some cases the molar ratio of F1 + 2 and TAT was reduced from the relationship normally seen in vitro and ex vivo in clinical thrombosis. There was a dramatic fall in factor V and VIII levels which occurred 4-6 hours before the decline in prothrombin and AT3. This related in time to a fall in alpha2AP and plasminogen. Protein C levels also declined dramatically but many hours after presentation.
Conclusions: F1 + 2 and TAT are sensitive markers of tiger snake evenomation. In some patients with massive prothrombin activation, the common mechanism for TAT clearance may be altered or overwhelmed. Conversely, the renal clearance of the smaller F1 + 2 may be enhanced. In the absence of thrombocytopaenia, which is a very sensitive marker of DIC, the fall in labile factors with tiger snake envenomation is significantly contributed to by proteolytic digestion of clotting factors.
- Comments:
Comment in: Pathology. 2002 Oct;34(5):481-2; author reply 482-3. (PMID: 12408355)
Comment in: Pathology. 2002 Dec;34(6):588-90; author reply 590. (PMID: 12556002)
- Accession Number:
0 (Antivenins)
0 (Elapid Venoms)
0 (antithrombin III-protease complex)
9000-94-6 (Antithrombin III)
9001-26-7 (Prothrombin)
9001-32-5 (Fibrinogen)
EC 3.4.- (Peptide Hydrolases)
- Publication Date:
Date Created: 20020515 Date Completed: 20021203 Latest Revision: 20190906
- Publication Date:
20240829
- Accession Number:
10.1080/003130201201118098
- Accession Number:
12009099
No Comments.